I can't recall who, but did someone say that one o
Post# of 148179
Quote:NP indicated that NYSE required the equivalent of the previous 12 months of expenses -- which in CytoDyn's case is $55M.
I can't recall who, but did someone say that one of the requirements to uplist is to have enough cash to cover 18 months of operations?